Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Download

Total Articles

1
(from Reference Citation Analysis)

Article PDFs (1)

Cited by > 0 (1)

Searched Name

Cyclin D2/drug effects

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Publication Title Analysis
Category Analysis

Results Analysis

Indexed Articles

Year Published

Show more Refine

Article Type

Show more Refine

Article Statistics

Refine

MESH Headings

Show more Refine

First Author

Show more Refine

First Author Affiliations

Show more Refine

Authors

Show more Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Countries/Regions

Show more Refine

Affiliations

Show more Refine

Corresponding Author Affiliations

Show more Refine

Category

Show more Refine

Number

Citation Analysis

Bandopadhayay P, Piccioni F, O'Rourke R, Ho P, Gonzalez EM, Buchan G, Qian K, Gionet G, Girard E, Coxon M, Rees MG, Brenan L, Dubois F, Shapira O, Greenwald NF, Pages M, Balboni Iniguez A, Paolella BR, Meng A, Sinai C, Roti G, Dharia NV, Creech A, Tanenbaum B, Khadka P, Tracy A, Tiv HL, Hong AL, Coy S, Rashid R, Lin JR, Cowley GS, Lam FC, Goodale A, Lee Y, Schoolcraft K, Vazquez F, Hahn WC, Tsherniak A, Bradner JE, Yaffe MB, Milde T, Pfister SM, Qi J, Schenone M, Carr SA, Ligon KL, Kieran MW, Santagata S, Olson JM, Gokhale PC, Jaffe JD, Root DE, Stegmaier K, Johannessen CM, Beroukhim R. Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma. Nat Commun 2019;10:2400. [PMID: 31160565 PMCID: PMC6546744 DOI: 10.1038/s41467-019-10307-9] [Citation(s) in RCA: 27] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2018] [Accepted: 04/25/2019] [Indexed: 12/26/2022] Open

Affiliation(s)

Pratiti Bandopadhayay Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, USA Broad Institute of MIT and Harvard, Cambridge, USA Department of Pediatrics, Harvard Medical School, Boston, USA
Federica Piccioni Broad Institute of MIT and Harvard, Cambridge, USA
Ryan O'Rourke Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, USA Broad Institute of MIT and Harvard, Cambridge, USA
Patricia Ho Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, USA Broad Institute of MIT and Harvard, Cambridge, USA
Elizabeth M Gonzalez Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, USA Broad Institute of MIT and Harvard, Cambridge, USA
Graham Buchan Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, USA Broad Institute of MIT and Harvard, Cambridge, USA
Kenin Qian Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, USA Broad Institute of MIT and Harvard, Cambridge, USA
Gabrielle Gionet Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, USA Broad Institute of MIT and Harvard, Cambridge, USA
Emily Girard Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, USA
Margo Coxon Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, USA
Matthew G Rees Broad Institute of MIT and Harvard, Cambridge, USA
Lisa Brenan Broad Institute of MIT and Harvard, Cambridge, USA
Frank Dubois Broad Institute of MIT and Harvard, Cambridge, USA Division of Cancer Biology, Dana-Farber Cancer Institute, Boston, USA
Ofer Shapira Broad Institute of MIT and Harvard, Cambridge, USA Division of Cancer Biology, Dana-Farber Cancer Institute, Boston, USA
Noah F Greenwald Broad Institute of MIT and Harvard, Cambridge, USA Division of Cancer Biology, Dana-Farber Cancer Institute, Boston, USA Department of Neurosurgery, Brigham and Women's Hospital, Boston, USA
Melanie Pages Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, USA Broad Institute of MIT and Harvard, Cambridge, USA
Amanda Balboni Iniguez Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, USA Broad Institute of MIT and Harvard, Cambridge, USA
Brenton R Paolella Broad Institute of MIT and Harvard, Cambridge, USA Division of Cancer Biology, Dana-Farber Cancer Institute, Boston, USA
Alice Meng Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
Claire Sinai Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, USA Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
Giovanni Roti Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, USA Broad Institute of MIT and Harvard, Cambridge, USA Department of Medicine and Surgery, Hematology and BMT, University of Parma, Parma, Italy
Neekesh V Dharia Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, USA Broad Institute of MIT and Harvard, Cambridge, USA Department of Pediatrics, Harvard Medical School, Boston, USA
Amanda Creech Broad Institute of MIT and Harvard, Cambridge, USA
Benjamin Tanenbaum Broad Institute of MIT and Harvard, Cambridge, USA
Prasidda Khadka Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, USA Broad Institute of MIT and Harvard, Cambridge, USA Department of Pediatrics, Harvard Medical School, Boston, USA
Adam Tracy Broad Institute of MIT and Harvard, Cambridge, USA
Hong L Tiv Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Boston, USA
Andrew L Hong Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, USA Broad Institute of MIT and Harvard, Cambridge, USA Department of Pediatrics, Harvard Medical School, Boston, USA
Shannon Coy Department of Pathology, Brigham and Women's Hospital, Boston, USA
Rumana Rashid Department of Pathology, Brigham and Women's Hospital, Boston, USA Department of Biomedical Informatics, Harvard Medical School, Boston, USA
Jia-Ren Lin Laboratory of Systems Pharmacology, Harvard Medical School, Boston, USA Ludwig Center for Cancer Research at Harvard, Harvard Medical School, Boston, USA
Glenn S Cowley Broad Institute of MIT and Harvard, Cambridge, USA Discovery Science, Janssen Research and Development (Johnson & Johnson), Spring House, PA, USA
Fred C Lam Koch Institute for Integrative Cancer Research, MIT, Cambridge, USA
Amy Goodale Broad Institute of MIT and Harvard, Cambridge, USA
Yenarae Lee Broad Institute of MIT and Harvard, Cambridge, USA
Kathleen Schoolcraft Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
Francisca Vazquez Broad Institute of MIT and Harvard, Cambridge, USA
William C Hahn Broad Institute of MIT and Harvard, Cambridge, USA Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA Department of Medicine, Harvard Medical School, Boston, USA
Aviad Tsherniak Broad Institute of MIT and Harvard, Cambridge, USA
James E Bradner Broad Institute of MIT and Harvard, Cambridge, USA Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA Department of Medicine, Harvard Medical School, Boston, USA Novartis Institutes for Biomedical Research, Basel, Switzerland
Michael B Yaffe Broad Institute of MIT and Harvard, Cambridge, USA Koch Institute for Integrative Cancer Research, MIT, Cambridge, USA
Till Milde Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany CCU Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany Department of Pediatric Oncology, Hematology, and Immunology, Center for Child and Adolescent Medicine, Heidelberg University Hospital, Heidelberg, Germany
Stefan M Pfister Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany Division of Pediatric Neuro-Oncology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany
Jun Qi Division of Cancer Biology, Dana-Farber Cancer Institute, Boston, USA
Monica Schenone Broad Institute of MIT and Harvard, Cambridge, USA
Steven A Carr Broad Institute of MIT and Harvard, Cambridge, USA
Keith L Ligon Broad Institute of MIT and Harvard, Cambridge, USA Department of Pathology, Brigham and Women's Hospital, Boston, USA Department of Medicine, Harvard Medical School, Boston, USA Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, USA Department of Pathology, Boston Children's Hospital, Boston, USA
Mark W Kieran Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, USA Department of Pediatrics, Harvard Medical School, Boston, USA
Sandro Santagata Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA Department of Pathology, Brigham and Women's Hospital, Boston, USA
James M Olson Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, USA
Prafulla C Gokhale Experimental Therapeutics Core and Belfer Center for Applied Cancer Science, Boston, USA
Jacob D Jaffe Broad Institute of MIT and Harvard, Cambridge, USA
David E Root Broad Institute of MIT and Harvard, Cambridge, USA
Kimberly Stegmaier Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, USA Broad Institute of MIT and Harvard, Cambridge, USA Department of Pediatrics, Harvard Medical School, Boston, USA
Cory M Johannessen Broad Institute of MIT and Harvard, Cambridge, USA.
Rameen Beroukhim Broad Institute of MIT and Harvard, Cambridge, USA. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, USA. Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. Department of Medicine, Harvard Medical School, Boston, USA.

Collapse